Detalles de la búsqueda
1.
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation.
Br J Cancer;
128(2): 266-274, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36396818
2.
The Impact of COVID-19 on Treatment Practices for Patients With Early Breast Cancer: A Cross-Sectional Study From a Large Cancer Center in Italy.
Oncologist;
28(12): e1179-e1184, 2023 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37699107
3.
Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy.
Oncologist;
28(9): e703-e711, 2023 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36940301
4.
The histomorphological and molecular landscape of colorectal adenomas and serrated lesions.
Pathologica;
113(3): 218-229, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34294939
5.
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer.
Oncologist;
25(9): e1355-e1362, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32618068
6.
The Tumor Microenvironment of Primitive and Metastatic Breast Cancer: Implications for Novel Therapeutic Strategies.
Int J Mol Sci;
21(21)2020 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33143050
7.
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation.
Br J Cancer;
128(2): 398, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36460777
8.
PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2- BC patients with residual disease after neoadjuvant chemotherapy: a cohort study.
J Clin Pathol;
2023 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37344170
9.
A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast Cancer.
Clin Cancer Res;
29(17): 3429-3437, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37417941
10.
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment.
NPJ Breast Cancer;
8(1): 66, 2022 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35595761
11.
Gastric metastases of breast cancer: Histopathological and molecular characterization of a single Institution case series.
Pathol Res Pract;
233: 153872, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35390634
12.
Morphological and molecular characterization of colorectal sessile serrated lesions with dysplasia.
Pathol Res Pract;
240: 154214, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36395596
13.
Neoadjuvant Chemotherapy and Immunotherapy in Luminal B-like Breast Cancer: Results of the Phase II GIADA Trial.
Clin Cancer Res;
28(2): 308-317, 2022 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34667023
14.
Evolution of HER2-low expression from primary to recurrent breast cancer.
NPJ Breast Cancer;
7(1): 137, 2021 Oct 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34642348
15.
ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis.
Front Oncol;
11: 625636, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33777770
16.
Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy.
NPJ Breast Cancer;
7(1): 101, 2021 Aug 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34341356
17.
Preoperative non-palpable breast lesion localization, innovative techniques and clinical outcomes in surgical practice: A systematic review and meta-analysis.
Breast;
58: 93-105, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33991806
18.
Synchronous nodal metastatic risk in screening detected and endoscopically removed pT1 colorectal cancers.
Pathol Res Pract;
216(6): 152966, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32360247
19.
Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapy.
Eur J Cancer;
136: 7-15, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32622323
20.
Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases.
ESMO Open;
5(5): e000843, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33020219